Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has shared an update.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is undergoing a proposed pre-conditional privatization by Sunshine Lake Pharma Co., Ltd. through a merger by absorption. The merger is contingent upon several pre-conditions, including regulatory approvals and shareholder agreement, some of which have yet to be fulfilled. The merger’s success remains uncertain as it is subject to conditions yet to be met, and stakeholders are advised to exercise caution.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company incorporated in the People’s Republic of China. The company operates in the pharmaceutical industry and is focused on the production and distribution of pharmaceutical products.
YTD Price Performance: 2.51%
Average Trading Volume: 2,704,049
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$8.62B
For detailed information about 1558 stock, go to TipRanks’ Stock Analysis page.
